Nicole Kruger - Director, NMK Consulting - Project Manager, International CRO
I have worked with and recommended Primorus for a number of clinical studies. The directors have extensive experience, either from working in pharmaceutical companies or acting as study investigators. This range of experience and understanding of the research environment means that the studies they conduct are well set up, well resourced with appropriate staff, and the work is conducted according to protocol and regulatory requirements and sponsor timelines. They know their market and can provide realistic estimates of recruitment, time, and costs, which greatly assists in project management. Their focus on quality means they can be relied upon to meet their commitments and produce excellent work.
Senior CRA, International CRO
It was a pleasure to work with such a dedicated, professional and efficient team. From the feasibility stage through to study close out, this site was proactive and responsive. Often demonstrating innovative ideas to assist patient recruitment and meeting study milestones. The staff were always welcoming and the Principal Investigator, Dr Luckey is interested in the study and available to the Monitors. The facilities were conducive for successful trial conduct. Overall we felt like a cohesive team working with the Primorus staff to achieve the common study goals. I would not hesitate to work on another study with this delightful group.
Project Manager, International CRO
I have recently had the pleasure of working with Primorus Clinical Trials on a phase II, asthma drug trial. The staff at Primorus provided a professional service with a friendly approach. The team, headed up by Dr. Luckey, always made themselves available to our staff and actively pursued any issues to resolution. They efficiently met all milestones and exceeded their patient recruitment target. I hope I have the opportunity to work with them again in the future.
National Business Review
Primorus was voted the 6th most exciting company in the NZ pharmaceutical sector in a recent survey conducted by strategic business consultancy, New River, and reported in the NBR.
